Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

Index- P/E- EPS (ttm)-0.33 Insider Own93.84% Shs Outstand13.01M Perf Week350.43%
Market Cap240.74M Forward P/E- EPS next Y- Insider Trans0.00% Shs Float0.80M Perf Month416.76%
Income-4.30M PEG- EPS next Q- Inst Own0.24% Short Float0.49% Perf Quarter239.45%
Sales0.00M P/S- EPS this Y- Inst Trans56.54% Short Ratio0.01 Perf Half Y230.36%
Book/sh0.63 P/B29.29 EPS next Y- ROA-40.85% Short Interest0.00M Perf Year134.18%
Cash/sh0.61 P/C30.24 EPS next 5Y- ROE-42.49% 52W Range3.03 - 32.44 Perf YTD274.49%
Dividend Est.- P/FCF- EPS past 5Y-60.65% ROI-52.18% 52W High-42.97% Beta-2.19
Dividend TTM- Quick Ratio41.92 Sales past 5Y0.00% Gross Margin- 52W Low510.56% ATR (14)1.82
Dividend Ex-DateFeb 15, 2018 Current Ratio41.92 EPS Y/Y TTM26.73% Oper. Margin- RSI (14)87.25 Volatility74.64% 24.88%
Employees12 Debt/Eq0.01 Sales Y/Y TTM- Profit Margin- Recom- Target Price-
Option/ShortNo / No LT Debt/Eq0.00 EPS Q/Q15.45% Payout- Rel Volume5.54 Prev Close12.62
Sales Surprise- EPS Surprise- Sales Q/Q- Earnings- Avg Volume551.13K Price18.50
SMA20213.36% SMA50271.09% SMA200215.36% Trades Volume3,356,394 Change46.59%
Mar-17-25 07:28AM
Jul-23-24 04:02PM
Nov-15-23 04:31PM
Jul-31-23 08:15AM
Apr-03-23 07:25AM
06:36AM Loading…
Feb-21-23 06:36AM
Nov-21-22 06:49AM
Nov-15-22 07:55AM
Oct-25-22 06:55AM
Sep-14-22 06:55AM
Sep-12-22 09:15AM
Jun-20-22 05:27AM
May-24-22 05:46AM
May-18-22 08:05AM
06:14AM
08:56AM Loading…
May-16-22 08:56AM
Apr-14-22 10:03AM
Apr-07-22 06:09AM
Mar-01-22 08:30AM
Feb-17-22 11:40AM
Feb-16-22 08:42PM
Dec-13-21 08:35AM
Nov-22-21 08:15AM
08:00AM
Nov-02-21 04:00AM
Oct-19-21 11:44AM
Sep-10-21 06:18AM
02:42AM
Sep-02-21 08:00AM
Aug-20-21 08:00AM
08:00AM Loading…
Aug-05-21 08:00AM
Jul-20-21 04:05PM
Jul-16-21 11:43AM
Regencell Bioscience Holdings Ltd. engages in the research, development, and commercialization of traditional Chinese medicine. It seeks the treatment of neurocognitive disorders and degeneration, specifically attention deficit hyperactivity disorder and autism spectrum disorder. The company was founded by Yat-Gai Au on October 30, 2014 and is headquartered in Hong Kong.